Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 8,245-8,256 of 10,612

Other study type icon

TerminatedNCT04353921

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionObservationalFrom 21 Years to 65 Years

Countries: United States
Sponsor: Usona Institute
Condition: Depression

Drug study icon

Active Not RecruitingNCT03554174

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Depression

Drug study icon

Active Not RecruitingNCT06308653

Psilocybin for Major Depressive Disorder (MDD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: Usona Institute
Condition: Depression

Drug study icon

Active Not RecruitingNCT05554094

Psilocybin for Veterans With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 21 Years to 64 Years

Countries: United States
Sponsor: Ohio State University
Condition: PTSD

Drug study icon

CompletedNCT03300947

Psilocybin for Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Arizona
Condition: OCD

Drug study icon

CompletedNCT06230757

Psilocybin for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 21 Years to 75 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: Depression

Drug study icon

CompletedNCT05399498

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Chicago
Condition: Depression

Drug study icon

CompletedNCT04932434

Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyDrugFrom 40 Years to 75 Years

Countries: United States
Sponsor: Joshua Woolley, MD, PhD
Condition: Depression, Anxiety

Drug study icon

Active Not RecruitingNCT05065294

Psilocybin Therapy for Depression in Bipolarity type II

This study is looking at determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolarity II. Participants receive a study treatment and complete follow-up visits and assessments.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Bipolarity, Depression

Drug study icon

Active Not RecruitingNCT04620759

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression, Addiction

Drug study icon

CompletedNCT05227612

Psilocybin-assisted CBT for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 21 Years to 60 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Depression

Drug study icon

CompletedNCT05847686

Psilocybin-Assisted Therapy for Cancer-Related Anxiety in people with Metastatic Cancer

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 85 Years

Countries: United States
Sponsor: University of Washington
Condition: Anxiety

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.